About: Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2007 (ast) vědecký článek publikovaný v roce 2007 (cs) наукова стаття, опублікована в березні 2007 (uk) 2007 թուականի Մարտին հրատարակուած գիտական յօդուած (hyw) 2007 թվականի մարտին հրատարակված գիտական հոդված (hy) مقالة علمية (نشرت في مارس 2007) (ar) wetenschappelijk artikel (gepubliceerd op 2007/03/01) (nl) vedecký článok (publikovaný 2007/03/01) (sk) scientific journal article (en) im März 2007 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q28571421-D40E0D8A-8710-4198-B994-01C5EA218B23
publication date	2007-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28571421-8C81201D-5DB9-49B3-B640-2289099E0169
language of work or name	English
cites work	wds:Q28571421-07F1E461-8E2E-4272-BB79-F7B5A88B2604 wds:Q28571421-0B380F6D-3439-44D6-9A85-063C87736B74 wds:Q28571421-15A07BFF-B28E-4B55-BD22-A4AC9F331ACB wds:Q28571421-1F3C3846-FD2B-4C0B-A17B-3093CF5A73BB wds:Q28571421-2379E0BD-FC57-4EAA-9EF6-408B49E5F952 wds:Q28571421-2648A354-2C3E-4354-8FBC-09B67E12B85D wds:Q28571421-26DAE8FE-5D5A-436E-A1D6-0B2595EA9D5C wds:Q28571421-281BB89D-6E11-4221-9D09-909A360A4863 wds:Q28571421-3B7861BB-BF10-4019-9E45-662875153A25 wds:Q28571421-3B946D5B-3CB7-4976-B451-D92D418F0ECC wds:Q28571421-43826AD6-FFDC-4CBF-9248-2853D9FA5094 wds:Q28571421-46DC60E9-8D36-4536-8CCB-0F80C3FD03EB wds:Q28571421-4C3FBC63-A10A-4034-B257-96D81E66ADD1 wds:Q28571421-518E14B0-7D15-496A-B8C9-0D65F1EA639C wds:Q28571421-58B2AEB7-D3B2-44E9-B761-D3EC682AFF95 wds:Q28571421-6955670A-FA8F-4580-91BB-AF15E8D81EEF wds:Q28571421-71433D79-4142-44E0-B176-A3AFD843B9E7 wds:Q28571421-714B028F-E8B1-459C-AF45-744A44B059F0 wds:Q28571421-76696AB8-7766-4C15-9E0D-E8E004AC40F9 wds:Q28571421-79DA6793-ADE0-4A44-B178-1CEF864787D4 wds:Q28571421-9EA7AA70-23A5-44D2-BC0E-7C55C6EF6611 wds:Q28571421-A96ED7F7-46E4-47C2-912E-7146F5187148 wds:Q28571421-B3C43379-55E8-4DB4-9E58-43AC3F3FC4C4 wds:Q28571421-B6A73D07-8896-4D75-B48E-59E13B751CD7 wds:Q28571421-BA298072-E6C0-4F4C-8B38-2195F10C629C wds:Q28571421-BB28C044-0EAE-492A-93F8-EA5ADD288AC0 wds:Q28571421-BC5C9027-648E-41CB-957D-BF88FC201BD3 wds:Q28571421-C22A4994-5466-49C1-8322-297FC98B1972 wds:Q28571421-C6151299-1BDD-4E10-9D55-081C97BD49B6 wds:Q28571421-C61F34A9-10D9-4B39-A14B-0A113BA94FE0 wds:Q28571421-C68EDF36-A292-4705-B71B-0B8E0B4BF4D5 wds:Q28571421-C74AF500-F4FB-4E35-BFDD-589C95389422 wds:Q28571421-D0D5C506-4AEF-46D0-AC84-1B82034CDB13 wds:Q28571421-E166AEFF-3E09-4DD0-B4F3-2F643A83BDE8
cites work	Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle Regulation of fasted blood glucose by resistin A new mathematical model for relative quantification in real-time RT-PCR A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION Inflammation and insulin resistance Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance Characterization of the insulin receptor kinase purified from human placental membranes Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy Fasting does not impair insulin-stimulated glucose uptake but alters intracellular glucose metabolism in conscious rats. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity Protein kinase C isoforms epsilon, eta, delta and zeta in murine adipocytes: expression, subcellular localization and tissue-specific regulation in insulin-resistant states In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration. Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. Protein kinase C-epsilon promotes adipogenic commitment and is essential for terminal differentiation of 3T3-F442A preadipocytes Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation PKCepsilon induces interleukin-6 expression through the MAPK pathway in 3T3-L1 adipocytes Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered Regulation of the insulin receptor by protein kinase C isoenzymes: preferential interaction with β isoenzymes and interaction with the catalytic domain of βII Phorbol ester-mediated protein kinase C interaction with wild-type and COOH-terminal truncated insulin receptors
author name string	wds:Q28571421-F1C851A1-F0A7-4A78-8992-BB596967932F
OpenCitations bibliographic resource ID	wds:Q28571421-EDD25AE2-D28A-4B0D-8080-E9CB588FAA4F
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/2578700
author name string	Amy Wang
OpenCitations bibliographic resource ID	2578700
rdfs:label	Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease (en) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease (nl) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease (ast)
skos:prefLabel	Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease (en) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease (nl) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease (ast)
name	Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease (en) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease (nl) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease (ast)
author	wds:Q28571421-3695C142-2F14-4BB9-8201-B2A62D076CB7 wds:Q28571421-486DE7D1-3840-4921-98FB-D5642CDA1D88 wds:Q28571421-4EFBA9EE-4336-4715-9E89-C88DCB4251DD

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software